Purpose To describe the characteristics, outcomes, and risk factors associated with poor
outcome of venoarterial extracorporeal membrane oxygenation (VA-ECMO)-treated patients …

Purpose Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) may provide
benefit to patients in refractory cardiac arrest and cardiogenic shock. We aim to summarize …

Background Cardiogenic shock and cardiac arrest are life-threatening emergencies with
high mortality rates. Veno-arterial extracorporeal membrane oxygenation (VA ECMO) and …

Purpose Cardiogenic shock due to post-resuscitation myocardial dysfunction is a major
cause of mortality among patients hospitalized after cardiac arrest (CA). Veno-arterial …

Objective To evaluate the effect of extracorporeal membrane oxygenation (ECMO) on
survival and complication rates in adults with refractory cardiogenic shock or cardiac arrest …

Refractory cardiogenic shock (RCS) is associated with significant morbidity and mortality,
and current mainstays of medical therapy appear inadequate. Venoarterial extracorporeal …

We retrospectively assessed the experience of our tertiary care center on the use of venous-
arterial extracorporeal membrane oxygenation (VA-ECMO) in 16 adult patients with …

Mortality due to refractory cardiogenic shock (RCS) exceeds 50%. Venoarterial
extracorporeal membrane oxygenation (VA-ECMO) has become an accepted therapy for …

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is
increasingly being used for circulatory support in patients with cardiogenic shock, although …

Purpose This study was designed to examine the long-term survival of patients who survived
to be weaned from venoarterial extracorporeal membrane oxygenation (VA ECMO) and to …